Clinical Trials in San Francisco

Showing 10721-10740 of 12,991 trials

COMPLETEDPhase 3< 1 mile

Maintaining Nonsmoking: Older Smokers - 1

NCT00086385

The purpose of this study was to examine pharmacological and psychological interventions for smokers over 50.

Tobacco Use Disorder

University of California, San Francisco403 participantsStarted Sep 2001

San Francisco, California, United States

COMPLETEDPhase 2< 1 mile

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

NCT00307125

The purpose of this study is to determine whether treatment with rituximab (anti-CD20, Rituxan®, MabThera®) in individuals who develop new anti-HLA antibodies after renal (kidney) transplant will promote longer-term survival of the transplanted kidney.The pilot study compares the use of rituximab (Rituxan®) + site-specific standard immunosuppression to placebo + site-specific standard immunosuppression in the treatment of circulating anti-HLA antibodies in subjects who develop de novo anti-HLA antibodies between 3-36 months after transplant.

Kidney TransplantKidney Transplant RecipientGraft Function/Survival+1 more

National Institute of Allergy and Infectious Diseases (NIAID)757 participantsStarted Mar 2006

Birmingham, Alabama, United States • Birmingham, Alabama, United States • San Francisco, California, United States +14 more locations

Maintaining Nonsmoking: Older Smokers - 1

Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies

Find Trials by Condition in San Francisco

Assessing HIV-Related Oral Mucosal Disease and Using Saliva to Measure Viral Load

An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

Effects of HQK-1001 in Patients With Sickle Cell Disease

Dialysis Clinical Outcomes Revisited (DCOR) Trial

Prospective Study Evaluating the Treatment of Hyperdynamic Forehead Wrinkles

Phase IIIB Subcutaneous Abatacept Monotherapy Study

TeleQuit Smoking Cessation Program

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

Patient-Reported Outcomes in Adults With Congenital Heart Disease

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB)

NVA237 BID Versus Placebo Twelve-week Efficacy Study

Clinical Investigation of Expanded Designs of a Multifocal IOL

Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis

Study of Plerixafor Combined With Cytarabine and Daunorubicin in Patients With Newly Diagnosed Acute Myeloid Leukemia

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women